Common use of BY AND BETWEEN Clause in Contracts

BY AND BETWEEN. Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Xxxxxxx By: /s/ Xxxx Xxxxx Name: Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Name: Xxxx Xxxxx CEO Title: Title: Research & Development Date: 17 October 2006 Date: 10/24/06 [SEAL] **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Change Order #01 to Exhibit I to the Clinical Services Master Agreement between Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 2005. THIS CHANGE ORDER is entered into this 20th day of November 2006 (“Effective Date”), by and between Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Xxxxxx Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Xxxxxxx Mxxxxxx Xxxxxxxx By: /s/ Xxxx Dxxx Xxxxx Name: Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Mxxxxxx Xxxxxxxx Name: Xxxx Dxxx Xxxxx CEO Title: Director Title: Research & Development DateCEO Dated: 17 October 2006 Date4-Oct-06 Dated: 10/24/06 [SEAL] 10/10/06 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 406 of the Securities Exchange Act of 19341933, as amended. Change Order #01 05 to Exhibit I A to the Clinical Services Master Agreement between Xxxxxx Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 24th August 2005. THIS CHANGE ORDER is entered into this 20th day 18th Day of November 2006 January, 2007 (“Effective Date”), by and between Xxxxxx Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Xxxxxx Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Xxxxxxx ByName: Title: /s/ Xxxx Xxxxx Name: Xxxxx Pxxxx Xxxxxxx Pxxxx Xxxxxxx Chief Scientific Officer and Vice President, Reasearch & Developement By: Name: Xxxx Xxxxx CEO Title: Title: Research & Development Date/s/ KXXXX X. XXXXX KXXXX X. XXXXX EXECUTIVE VICE PRESIDENT GLOBAL BUSINESS DEVELOPMENT CHIEF RELATIONS OFFICER Dated: 17 October 2006 Date25/5/06 Dated: 10/24/06 [SEAL] 6/6/06 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 406 of the Securities Exchange Act of 19341933, as amended. Change Order #01 02 to Exhibit I E to the Clinical Services Master Agreement between Xxxxxx Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 19th December 2005. THIS CHANGE ORDER is entered into this 20th 1st day of November 2006 (“Effective Date”), by and between Xxxxxx Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Xxxxxxx By: /s/ Xxxx Xxxxx Name: Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Name: Xxxx Xxxxx CEO Title: Title: Research & Development Date: 17 October 2006 Date: 10/24/06 [SEAL] **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 406 of the Securities Exchange Act of 19341933, as amended. Change Order #01 to Exhibit I to the Clinical Services Master Agreement between Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 2005. THIS CHANGE ORDER is entered into this 20th day of November 2006 (“Effective Date”), by and between Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Xxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Xxxxxxx By: /s/ Xxxx Xxxxx X. Xxxxx Name: Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Name: Xxxx Xxxxx CEO X. Xxxxx Title: Director, Drug Development Title: Research Senior Vice President Marketing & Business Development DateDated: 17 October 2006 Date3, 2005 Dated: 10/24/06 [SEAL] 10/24/05 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Change Order #01 02 to Exhibit I A to the Clinical Services Master Agreement between Xxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 24th August 2005. THIS CHANGE ORDER is entered into this 20th 24th day of November 2006 October, 2005 (“Effective Date”), by and between Xxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Xxxxxx Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Xxxxxxx Mxxxxxx Xxxxxxxx By: /s/ Xxxx Dxxx Xxxxx Name: Xxxxx Xxxxxxx Chief Scientific Officer and Vice President, Mxxxxxx Xxxxxxxx Name: Xxxx Dxxx Xxxxx Title: Managing Director & CEO Title: TitleCEO Dated: Research & Development Date4-oct-06 Dated: 17 October 2006 Date: 10/24/06 [SEAL] 10/10/06 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 406 of the Securities Exchange Act of 19341933, as amended. Change Order #01 to Exhibit I C to the Clinical Services Master Agreement between Xxxxxx Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 200524-08-05. THIS CHANGE ORDER EXHIBIT C is entered into this 20th 24th day of November 2006 August, 2005 (“Effective Date”), by and between Xxxxxx Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).

BY AND BETWEEN. Xxxxxx Pxxxxx Operations Pty Ltd. Omnicare CR, Inc. By: /s/ Xxxxx Pxxxx Xxxxxxx By: /s/ Xxxx Kxxxx X. Xxxxx Name: Xxxxx Pxxxx Xxxxxxx Chief Scientific Officer and Vice President, Name: Xxxx Kxxxx X. Xxxxx CEO Title: Director, Drug Development Title: Research Senior Vice President Marketing & Business Development DateDated: 17 October 2006 Date3, 2005 Dated: 10/24/06 [SEAL] 10/24/05 **** Certain confidential information contained in this document, marked with four asterisks, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 406 of the Securities Exchange Act of 19341933, as amended. Change Order #01 02 to Exhibit I A to the Clinical Services Master Agreement between Xxxxxx Pxxxxx Operations Pty Ltd. and Omnicare CR, Inc., dated 1st June 24th August 2005. THIS CHANGE ORDER is entered into this 20th 24th day of November 2006 October, 2005 (“Effective Date”), by and between Xxxxxx Pxxxxx Operations Pty Ltd. (hereinafter “Sponsor”) and Omnicare CR, Inc. (hereinafter “Omnicare CR”).